DrugPipeline.net has announced the addition of “Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 08/09/2016 --COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.

Report forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- Boehringer Ingelheim
- GSK
- Merck
- Novartis
- Teva

Other prominent vendors
- Ache Laboratorios Farmaceuticos
- Almirall
- Aquinox Pharmaceuticals
- Ario Pharma
- Asmacure
- Astellas Pharma
- BioMarck Pharmaceuticals
- Chiesi Farmaceutici
- Cytokinetics
- F. Hoffmann-La Roche
- Gilead Sciences
- Innoviva
- Invion
- MediciNova
- Mereo BioPharma
- Mylan
- Orion Corporation
- Palobiofarma
- Pearl Therapeutics
- Pharmaxis
- Prosonix
- Pulmagen Therapeutics
- RespiVert
- SolAeroMed
- Sunovion Pharmaceuticals
- Theravance Biopharma
- Theron Pharmaceuticals
- Verona Pharma
- Xention
- Yungjin Pharm
- ZAI Lab

Market driver
- Uptake of LABA/LAMA combination therapies
- For a full, detailed list, view our report

Market challenge
- Negligence toward use of controller medications
- For a full, detailed list, view our report

Market trend
- Increased adoption of e-cigarettes and smoking cessation products
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 107 pages "Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Pipeline analysis, Market landscape, Key buying criteria for COPD drugs, Market segmentation by drug class, Segmentation by ROA, Drug delivery devices market for COPD drugs, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-chronic-obstructive-pulmonary-disease-drugs-market-2016-2020

Related Reports:

Global PET Scanners Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-pet-scanners-market-2016-2020

Neurodiagnostic and Monitoring Devices Market in the US 2016-2020; visit - http://www.drugpipeline.net/technavio/neurodiagnostic-and-monitoring-devices-market-us-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.